[1]
A. Farooq, M. Abbasi, M. khawar, and N. Sheikh, “Overview of the advantages and disadvantages of chimeric antigen receptor T cell therapy in the tumor microenvironment”, BMRAT, vol. 9, no. 10, pp. 5341-5350, Oct. 2022.